facebook
eISSN: 2084-9893
ISSN: 0033-2526
Dermatology Review/Przegląd Dermatologiczny
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
3/2022
vol. 109
 
Share:
Share:
abstract:
Review article

Immunological abnormalities in lichen planus

Aleksandra Ostrowska
1, 2
,
Anna Susło
1, 3

1.
Department of Dermatology, Medical University of Warsaw, Warsaw, Poland
Katedra i Klinika Dermatologiczna, Warszawski Uniwersytet Medyczny, Warszawa, Polska
2.
Wolski Hospital Dr Anna Gostyñska, Warsaw, Poland
Szpital Wolski im. dr Anny Gostyñskiej, Warszawa, Polska
3.
Central Clinical Hospital of the Ministry of the Interior and Administration, Warsaw, Poland
Centralny Szpital Kliniczny MSWiA, Warszawa, Polska
Dermatol Rev/Przegl Dermatol 2022, 109, 217-228
Online publish date: 2022/10/21
View full text Get citation
 
PlumX metrics:
Lichen planus is a chronic disease associated with the occurrence of characteristic papular pruritic lesions. The most significant immunological markers of lichen planus are cytokines. Numerous publications showed changes in the serum level of tumor necrosis factor, interferon g, interleukins 2, 4, 6, 8, 10, 17 and 22. Early lichen planus is associated with a high number of macrophages, T cells, and dendritic cells, while advanced lichen planus with a high number of Treg cells. There is no single specific marker for lichen planus, but certain cytokine levels can be used as a prognostic factor for disease progression and as an indicator of treatment response. Analysis of the immune markers can help to define the disease stage and lichen planus subtype, but histopathology still remains a standard in lichen planus diagnosis.
keywords:

cytokines, biomarkers, lichen planus, immunologic factors



Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.